KPWS
PFE icon

Kestra Private Wealth Services’s Pfizer PFE Stock Holding History

Kestra Private Wealth Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Sell
297,975
-3,901
-1% -$102K 0.08% 259
2026
Q1 		$8.48M Sell
301,876
-29,865
-9% -$795K 0.1% 223
2025
Q4 		$8.26M Sell
331,741
-28,837
-8% -$727K 0.1% 218
2025
Q3 		$9.19M Buy
360,578
+56,991
+19% +$1.41M 0.12% 193
2025
Q2 		$7.36M Buy
303,587
+3,791
+1% +$88.4K 0.11% 219
2025
Q1 		$7.6M Buy
299,796
+3,533
+1% +$92.4K 0.13% 181
2024
Q4 		$7.86M Buy
296,263
+8,069
+3% +$219K 0.13% 172
2024
Q3 		$8.34M Sell
288,194
-33,154
-10% -$967K 0.15% 149
2024
Q2 		$8.99M Buy
321,348
+8,453
+3% +$233K 0.18% 129
2024
Q1 		$8.68M Buy
312,895
+22,691
+8% +$630K 0.2% 127
2023
Q4 		$8.35M Buy
290,204
+8,322
+3% +$252K 0.21% 117
2023
Q3 		$9.35M Buy
281,882
+22,430
+9% +$793K 0.29% 86
2023
Q2 		$9.52M Buy
259,452
+39,934
+18% +$1.55M 0.33% 74
2023
Q1 		$8.96M Buy
219,518
+10,283
+5% +$444K 0.36% 71
2022
Q4 		$10.7M Buy
209,235
+24,017
+13% +$1.15M 0.54% 35
2022
Q3 		$8.11M Sell
185,218
-1,575
-0.8% -$76.5K 0.47% 44
2022
Q2 		$9.79M Sell
186,793
-5,263
-3% -$268K 0.56% 31
2022
Q1 		$9.94M Sell
192,056
-7,154
-4% -$371K 0.49% 37
2021
Q4 		$11.8M Buy
199,210
+15,946
+9% +$790K 0.56% 29
2021
Q3 		$7.88M Buy
183,264
+1,547
+0.9% +$68.5K 0.44% 44
2021
Q2 		$7.12M Sell
181,717
-2,427
-1% -$94.4K 0.43% 43
2021
Q1 		$6.67M Buy
184,144
+10,241
+6% +$364K 0.46% 43
2020
Q4 		$6.39M Buy
173,903
+1,451
+0.8% +$53.2K 0.47% 43
2020
Q3 		$6M Buy
+172,452
New +$6.05M 0.52% 41

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kestra Private Wealth Services's PFE Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $102K and leaving 297,975 shares worth $7.18M. The position accounts for 0.08% of the portfolio, ranked #259.

Kestra Private Wealth Services first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $11.8M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kestra Private Wealth Services held 297,975 shares of Pfizer worth $7.18M as of Q2 2026.
  • Kestra Private Wealth Services sold 3,901 Pfizer shares in Q2 2026, an estimated $102K.
  • Pfizer made up 0.08% of Kestra Private Wealth Services's portfolio in Q2 2026, its #259 holding.
  • Kestra Private Wealth Services first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • Kestra Private Wealth Services's Pfizer position peaked at $11.8M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.